SSA: Percentage of participants reporting adverse events;SSA: Percentage of participants reporting local reactions;SSA: Percentage of participants reporting serious adverse events;SSA: Percentage of participants reporting systemic events;SSA: Percentage of participants with abnormal troponin I laboratory values;SSA: Percentage of participants with abnormal troponin I laboratory values;SSA: Percentage of participants with new ECG abnormalities;SSA: Percentage of participants with new electrocardiogram (ECG) abnormalities;SSB Initial Enrollment: Percentage of participants with abnormal troponin I laboratory values;SSB Initial Enrollment: Percentage of participants with abnormal troponin I laboratory values;SSB Initial Enrollment: Percentage of participants with new electrocardiogram (ECG) abnormalities;SSB Initial Enrollment: Percentage of participants with new electrocardiogram (ECG) abnormalities;SSB: Percentage of participants reporting adverse events;SSB: Percentage of participants reporting local reactions;SSB: Percentage of participants reporting serious adverse events;SSB: Percentage of participants reporting systemic events

SSA: Percentage of participants reporting adverse events;SSA: Percentage of participants reporting local reactions;SSA: Percentage of participants reporting serious adverse events;SSA: Percentage of participants reporting systemic events;SSA: Percentage of participants with abnormal troponin I laboratory values;SSA: Percentage of participants with abnormal troponin I laboratory values;SSA: Percentage of participants with new ECG abnormalities;SSA: Percentage of participants with new electrocardiogram (ECG) abnormalities;SSB Initial Enrollment: Percentage of participants with abnormal troponin I laboratory values;SSB Initial Enrollment: Percentage of participants with abnormal troponin I laboratory values;SSB Initial Enrollment: Percentage of participants with new electrocardiogram (ECG) abnormalities;SSB Initial Enrollment: Percentage of participants with new electrocardiogram (ECG) abnormalities;SSB: Percentage of participants reporting adverse events;SSB: Percentage of participants reporting local reactions;SSB: Percentage of participants reporting serious adverse events;SSB: Percentage of participants reporting systemic events

Percentage of participants reporting adverse events;Percentage of participants reporting local reactions;Percentage of participants reporting serious adverse events;Percentage of participants reporting systemic events;Percentage of participants with abnormal troponin I laboratory values;Percentage of participants with abnormal troponin I laboratory values;Percentage of participants with new ECG abnormalities;Percentage of participants with new electrocardiogram (ECG) abnormalities

Percentage of participants reporting adverse events;Percentage of participants reporting local reactions;Percentage of participants reporting serious adverse events;Percentage of participants reporting systemic events;Percentage of participants with abnormal troponin I laboratory values;Percentage of participants with abnormal troponin I laboratory values;Percentage of participants with new ECG abnormalities;Percentage of participants with new electrocardiogram (ECG) abnormalities